Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
By Gustavo Saposnik, F. Barinagarrementería, Robert D. Brown, C. Bushnell, B. Cucchiara, M. Cushman, G. deVeber, José M. Ferro, Fong Y. Tsai. Stroke, 2011
1,734 citations recorded by the source corpus.
Subfields: Neurology
View Paper: https://www.semanticscholar.org/paper/263db60cea0d4d572aa8e32b7f358e3b477f37e5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
Citations in the corpus
- [Cerebral venous thrombosis]. (2013, background): “Transitoires Permanents Grossesse et post-partum Maladies inflammatoires Vascularites : lupus, maladie de Behçet, maladie de Wegener Sarcoïdose Maladies inflammatoires intestinales Maladies infectieuses Néoplasies SNC : abcès, empyème, méningite ORL : face, cou Systémiques : septicémie, endocardite,”
- European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology (2017, methodology): “The current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010 [1] and by the American Heart Association and American Stroke Society in 2011 [2].”
- Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage (2016, background): “In fact, anticoagulation therapy is recommended in patients with cerebral sinus thrombosis, even in the context of intraparenchymal hemorrhage [38–40].”